Variants at IRX4 as prostate cancer expression quantitative trait loci

European Journal of Human Genetics

Volumn 22, Issue 4, 2014, Pages 558-563

  Xu, Xing ^a   Hussain, Wasay M ^b   Vijai, Joseph ^a   Offit, Kenneth ^a   Rubin, Mark A ^b   Demichelis, Francesca ^b,c   Klein, Robert J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TRENTO   (Italy)

Author keywords

eQTL; Expression quantitative trait loci; GWAS; IRX4; Prostate cancer; Risk SNPs

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FOLLOW UP; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRX4 GENE; LYMPHOBLASTOID CELL LINE; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY;

CHROMOSOME MAPPING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; QUANTITATIVE TRAIT LOCI;

EID: 84896544856     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.195     Document Type: Article

References (53)

1. Murabito JM, Rosenberg CL, Finger D et al: A genome-wide association study of breast and prostate cancer in the NHLBI"s Framingham Heart Study. BMC Med Genet 2007; 8(Suppl 1): S6
2. Gudmundsson J, Sulem P, Steinthorsdottir V et al: Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007; 39: 977-983
3. Gudmundsson J, Sulem P, Manolescu A et al: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-637
4. Gudmundsson J, Sulem P, Rafnar T et al: Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008; 40: 281-283
5. Takata R, Akamatsu S, Kubo M et al: Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 2010; 42: 751-754
6. Gudmundsson J, Sulem P, Gudbjartsson DF et al: Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1122-1126
7. Eeles RA, Kote-Jarai Z, Giles GG et al: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40: 316-321
8. Thomas G, Jacobs KB, Yeager M et al: Multiple loci identified in a genome-wide association study of prostate cancer. NatgGenet 2008; 40: 310-315
9. Sun J, Zheng SL, Wiklund F et al: Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res 2009; 69: 10-15
10. Eeles RA, Kote-Jarai Z, Al Olama AA et al: Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41: 1116-1121
11. Maurano MT, Humbert R, Rynes E et al: Systematic localization of common disease-Associated variation in regulatory DNA. Science (New York, NY) 2012; 337: 1190-1195
12. Morley M, Molony CM, Weber TM et al: Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743-747
13. Cheung VG, Conlin LK, Weber TM et al: Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33: 422-425
14. Schadt EE, Monks SA, Drake TA et al: Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297-302
15. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ: Trait-Associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genet 2010; 6: E1000888
16. Dimas AS, Deutsch S, Stranger BE et al: Common regulatory variation impacts gene expression in a cell type-dependent manner. Science (New York, NY) 2009; 325: 1246-1250
17. Nica AC, Parts L, Glass D et al: The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study. PLoS Genet 2011; 7: E1002003
18. Grisanzio C, Werner L, Takeda D et al: Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci USA 2012; 109: 11252-11257
19. Pflueger D, Terry S, Sboner A et al: Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res 2011; 21: 56-67
20. Habegger L, Sboner A, Gianoulis TA et al: RSEQtools: A modular framework to analyze RNA-Seq data using compact, anonymized data summaries. Bioinformatics 2011; 27: 281-283
21. Barbieri CE, Baca SC, Lawrence MS et al: Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012; 44: 685-689
22. Setlur SR, Chen CX, Hossain RR et al: Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 229-239
23. Oldridge DA, Banerjee S, Setlur SR, Sboner A, Demichelis F: Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. Nucleic Acids Res 2010; 38: 3275-3286
24. Hindorff LA, Sethupathy P, Junkins HA et al: Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367
25. Chang B-L, Cramer SD, Wiklund F et al: Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 2009; 18: 1368-1375
26. Xu X, Valtonen-André C, Sävblom C, Halldén C, Lilja H, Klein RJ: Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels. Cancer Epidemiol Biomarkers Prev 2010; 19: 2035-2042
27. Gudmundsson J, Besenbacher S, Sulem P et al: Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010; 2: 62ra92
28. Altshuler DM, Gibbs RA, Peltonen L et al: International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58
29. Banerjee S, Oldridge D, Poptsova M, Hussain WM, Chakravarty D, Demichelis F: A computational framework discovers new copy number variants with functional importance. PLoS One 2011; 6: E17539
30. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300
31. Stranger BE, Nica AC, Forrest MS et al: Population genomics of human gene expression. Nat Genet 2007; 39: 1217-1224
32. Frazer KA, Ballinger DG, Cox DR et al: International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-861
33. Yeager M, Orr N, Hayes RB et al: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649
34. Haiman CA, Patterson N, Freedman ML et al: Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39: 638-644
35. Howie BN, Donnelly P, Marchini J: A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: E1000529
36. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073
37. Marchini J, Howie B: Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11: 499-511
38. Vijai J, Kirchhoff T, Gallagher D et al: Genetic architecture of prostate cancer in the Ashkenazi Jewish population. Br J Cancer 2011; 105: 864-869
39. Purcell S, Neale B, Todd-Brown K et al: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575
40. Demichelis F, Setlur SR, Banerjee S et al: Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc Natl Acad Sci USA 2012; 109: 6686-6691
41. Long Q-Z, Du Y-F, Ding X-Y et al: Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population. PLoS One 2012; 7: E37866
42. Wang M, Liu F, Hsing AW et al: Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: A case-control study in the ChinaPCa consortium. Carcinogenesis 2012; 33: 356-360
43. Batra J, Lose F, Chambers S et al: A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population. Am J Epidemiol 2011; 174: 1391-1395
44. Schumacher FR, Berndt SI, Siddiq A et al: Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011; 20: 3867-3875
45. Lindstrom S, Schumacher FR, Campa D et al: Replication of five prostate cancer loci identified in an Asian population - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2012; 21: 212-216
46. Haiman CA, Chen GK, Blot WJ et al: Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet 2011; 7: E1001387
47. Bao ZZ, Bruneau BG, Seidman JG, Seidman CE, Cepko CL: Regulation of chamberspecific gene expression in the developing heart by Irx4. Science (New York, NY) 1999; 283: 1161-1164
48. Bruneau BG, Bao ZZ, Fatkin D et al: Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol Cell Biol 2001; 21: 1730-1736
49. Nguyen HH, Takata R, Akamatsu S et al: IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. HumMol Genet 2012; 21: 2076-2085
50. Pomerantz MM, Shrestha Y, Flavin RJ et al: Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet 2010; 6: E1001204
51. Zeller T, Wild P, Szymczak S et al: Genetics and beyond - The transcriptome of human monocytes and disease susceptibility. PLoS One 2010; 5: E10693
52. Grisanzio C, Freedman ML: Chromosome 8q24-Associated cancers and MYC. Genes Cancer 2010; 1: 555-559
53. Pruim RJ, Welch RP, Sanna S et al: LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics (Oxford, UK) 2010; 26: 2336-2337